Jessica Robinson

Science nerd, event organiser. I mainly post about what interests me in #advancedtherapies #science #health #pharma. Views are my own.

[Jessica Robinson @BioPharmaJess]

Transparent mouse could improve cancer drug tests

"A new scanning method involving a see-through mouse could improve how cancer drugs are tested, by picking up tumours previously too small to detect...

The researchers say the met…https://t.co/0D5CSekdtN https://t.co/D2FRw012c6

[Jessica Robinson @BioPharmaJess]

A deal for the UK's association with the EU's €100bn (£85bn) Horizon research and innovation programme has been negotiated

#innovation #research #UK #EU #horizon2020 https://t.co/0oFmAl0oAq

[Jessica Robinson @BioPharmaJess]

🎆 Happy 75th birthday NHS 🏥 !

👩‍⚕️ We're offering all NHS employees 25% off next year's Advanced Therapies Congress (19-20 March 2024, London)

💡 Find out the latest in Advanced Therapies, cell and gene therapy research, clinical updates, and more!…https://t.co/Ss32TdRoEX

[Jessica Robinson @BioPharmaJess]

Here’s what we know about lab-grown meat and climate change:

"Soon, the menu in your favorite burger joint could include not only options made with meat, mushrooms, and black beans but also patties packed with lab-grown animal cel…https://t.co/1rOEspV3Wi https://t.co/UzEfgi2Umf

[Jessica Robinson @BioPharmaJess]

AI, Cell/Gene Therapy, Precision Medicine Drive Bullish Biotech Investment

"Survey of investors shows continued optimism for life sciences despite VC declines, antitrust and IP concerns"

#AI #celltherapy #genetherapy #precisionm…https://t.co/DDR05wNIHJ https://t.co/4Tx9J1rO5n

[Jessica Robinson @BioPharmaJess]

It's been a great few weeks for cell and gene therapy!

It feels like the industry is really having a moment with all these approvals, aquisitions, collaborations and successful rounds of funding.

#genetherapy #funding #advancedtherapies #celltherapy https://t.co/D23l4MywSc

[Jessica Robinson @BioPharmaJess]

BioMarin’s #hemophilia A gene therapy Roctavian wins #FDA approval after delay and rejection, priced at $2.9M

"The FDA approved the first gene therapy to treat the genetic bleeding disorder hemophilia A on Thursday, capping a tur…https://t.co/dBhSkQJhGf https://t.co/9nSYjvcZ0j

[Jessica Robinson @BioPharmaJess]

https://t.co/g2H8OcKdam

[Jessica Robinson @BioPharmaJess]

Warnings to Avoid Using CRISPR-Cas9 on Human Embryos Reinforced by New Findings

"Our results show that the use of CRISPR-Cas9 in early human embryos carries significant risks,”... “We have found that the DNA of embryo cells can b…https://t.co/Gc59mnrgT9 https://t.co/2r0BwbVjgu

[Jessica Robinson @BioPharmaJess]

Reminder that registration prices for this year's BioTechX USA will go up this Friday!

Who? 1,000+ biotech and pharma attendees
What? America’s most exciting biotechnology congress, bridging the gap between pharma, academia and clinicians to foster mean…https://t.co/14r36SJKw7

[Jessica Robinson @BioPharmaJess]

Scientists have coaxed human stem cells to organize themselves into embryo-like forms. The advancement could shed light on fertility.

"The researchers coaxed stem cells to mimic some of these cell types and then mixed them togethe…https://t.co/iaTxdM98Mj https://t.co/46S3TD8u9F

[Jessica Robinson @BioPharmaJess]

Excellent infographic and overview of companies working on allogeneic cell therapies!

#celltherapy #allogeneic #advancedtherapies https://t.co/7Ksi3FJPrb

[Jessica Robinson @BioPharmaJess]

Under the partnership between the government and Moderna, sealed last December, the company will invest in mRNA research programs in the U.K. and is constructing the Moderna Innovation and Technology Center at a science campus call…https://t.co/Z32ZT40Xcz https://t.co/VwWF5vwDOA

[Jessica Robinson @BioPharmaJess]

It’s the last day of the #FOBEU sale, you can get 10 tickets at 50% off!

#biologics #antibodies https://t.co/NchWpijhVk

[Jessica Robinson @BioPharmaJess]

FDA grants conditional approval to Sarepta Therapeutics’s gene therapy for Duchenne muscular dystrophy. The agency today approved the gene therapy, called Elevydis, for 4- and 5-year-olds, a sub-group that appeared to benefit in a…https://t.co/l7UHF4B3yb https://t.co/RncE2QiHA5

[Alliance for Regenerative Medicine (ARM) @alliancerm]

The momentum for gene therapy is growing! 🧬💪

The FDA has accepted a BLA for @bluebirdbio’s gene therapy to treat sickle cell disease and has set a decision date for December 20, 2023. 1/4 https://t.co/NSKwO2D1o9

[Jessica Robinson @BioPharmaJess]

The first cultivated, or lab-grown, meat has been approved for sale in the US.
Two California-based companies, Upside Foods and Eat Just, received grants of inspection from the United States Department of Agriculture today. It’s th…https://t.co/fGljNdJJxw https://t.co/oOvVxn83lm

[Jessica Robinson @BioPharmaJess]

Proposed joint clinical assessment methodology would have rejected nearly 90% of the ATMPs currently authorized in the EU

"Nearly 90% of the Advanced Therapy Medicinal Products (#ATMPs) currently authorized in the EU – including a…https://t.co/TQTbhxjuJk https://t.co/hbfz30dn7H

[Jessica Robinson @BioPharmaJess]

Ophthalmology specialist Iveric snapped up by Astellas for $5.9 billion

"The Japanese pharmaceutical giant Astellas Pharma has taken over the U.S. company Iveric Bio in a $5.9 billion deal to get hold of its ophthalmology-focused…https://t.co/4rHyfmvU03 https://t.co/SHdbHSiFiI

[Jessica Robinson @BioPharmaJess]

AstraZeneca drafts plan to spin off China business amid tensions

Anglo-Swedish drugmaker views listing a separate unit in Hong Kong as potential shelter from global strife

"Under the plans AstraZeneca, which is the UK’s biggest l…https://t.co/Wz4n6Rr8wp https://t.co/boy6jGhrtC